The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life Sciences Supplement.
The Supplement – created by M&A professionals from across our global Life Sciences sector team – covers M&A deal activity in 2022 and supplements our 2023 global M&A Intelligence Report, which is now in its ninth edition.
The report looks at a selection of our international corporate life sciences transactions to identify trends and developments, which can provide insightful intelligence for those operating in the sector and considering M&A activity, both domestically or internationally.
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-08-10-50-28-575-67050e74c71f57809f6d0411.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-20-00-19-07-074-6764b7fb8b43d2162bbda63e.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-17-10-04-22-244-67614ca6e47d4e3f62efe626.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-16-09-34-16-975-675ff418f1680c6c88e5b5fa.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-12-10-12-27-55-733-A26208_Life_Sciences_Brochure_November_Brochure_English_V1_thumbnail_1.png)
